Web Drugs for Neoplasia

download Web Drugs for Neoplasia

of 22

Transcript of Web Drugs for Neoplasia

  • 8/6/2019 Web Drugs for Neoplasia

    1/22

    Drugs for Neoplasia

    Chapter 37

  • 8/6/2019 Web Drugs for Neoplasia

    2/22

    Cancer: Basic Facts

    CarcinomaAbnormal, uncontrolled cell division

    Suppressor genesDamaged cells unresponsive to chemicalsignals

    Cancer cells create tumorsCancer cells can metastasizeNamed according to tissue of origin

  • 8/6/2019 Web Drugs for Neoplasia

    3/22

    Factors Causing or Associated with

    Increased Cancer RiskChemical carcinogensExcess x-ray exposure

    Ultraviolet light exposureVirusesImmune system suppression

    Genetic componentEnvironmental component

  • 8/6/2019 Web Drugs for Neoplasia

    4/22

    Lifestyle Risks

    Inadequate/improper nutritionChemical risks

    Noncompliance with screeningrecommendations

    Discuss lifestyle factors important to cancerprevention or diagnosis.

  • 8/6/2019 Web Drugs for Neoplasia

    5/22

    Curing Cancer

    Discuss challenges to curing cancer.

    Discuss treatment approaches: Surgery Radiation

    Chemotherapy

  • 8/6/2019 Web Drugs for Neoplasia

    6/22

    Antineoplastic Therapy

    Describe the generalpurposes of antineoplastic

    therapy.

  • 8/6/2019 Web Drugs for Neoplasia

    7/22

    Cell Cycle

    Figure 37.2 Antineoplastic agents and the cellcycle, p. 555

    Important to pharmacodynamics of antineoplastic therapy Some drugs are specific to certain cell cycle

    phases

    Growth Fraction Ratio of # of replicating cells to # of resting cells

  • 8/6/2019 Web Drugs for Neoplasia

    8/22

    Special Protocols and Strategies

    Protocols: Therapy will be designed to optimize cancer cell

    death. Specific dosing schedules

    Strategies: Multiple drugs from different classes Combination therapy

  • 8/6/2019 Web Drugs for Neoplasia

    9/22

    Toxicity

    Antineoplastics also affect normal cellsReplicating cells most susceptible

    Hair follicle, epithelial lining of gastric mucosaVomiting center triggeredPremedications may decrease toxic effects

    Bone marrow toxicity is most frequent dose-limiting effect

  • 8/6/2019 Web Drugs for Neoplasia

    10/22

    Bone Marrow Toxicity

    Discuss strategies tominimize bone marrow

    toxicity.

  • 8/6/2019 Web Drugs for Neoplasia

    11/22

    Nadir and Absolute Neutrophil Count

    Nadir: lowest point at which neutrophil countis depressed by the chemotherapeutic agent.p. 557

    Describe the significance of monitoring theabsolute neutrophil count.

  • 8/6/2019 Web Drugs for Neoplasia

    12/22

    Administration Considerations

    Identify delivery strategies to minimizesystemic toxicity.

    Discuss the practice implications of IVadministration of antineoplastics, most of which are vesicants.

    What must a nurse know before administeringan antineoplastic IV?

  • 8/6/2019 Web Drugs for Neoplasia

    13/22

    Q uestion

    Antineoplastic agents are toxic to normal cellsas well as cancer cells and can cause long termconsequences such as infertility and inductionof secondary malignancies.

    Why would drugs that could cause suchserious side effects and other cancers beadministered?

  • 8/6/2019 Web Drugs for Neoplasia

    14/22

  • 8/6/2019 Web Drugs for Neoplasia

    15/22

    Antineoplastic Drugs

    Develop a table to include: MOA

    Prototype and examples Indications for therapy Common adverse effects Nursing considerations Key teaching points

  • 8/6/2019 Web Drugs for Neoplasia

    16/22

    General Nursing Considerations

    Baseline: VS, CBC with Diff, RFTs, LFTs, I&O, wt. Hearing test with some drugs

    Cautious:

    hepatic, cardiac, renal impairment Recent steroids, leukopenia, thrombocytopenia

    Well hydrated prior to therapyAvoid crowds/those with respiratory infections

    Incorporate measures to facilitate respiratory functionBe alert for bruising and bleedingMonitor CBC and platelet count during therapy

  • 8/6/2019 Web Drugs for Neoplasia

    17/22

    General Nursing Considerations

    Anticipate side effects Premedicate with antiemetic

    Monitor nutritional intake

    Assess for n/v; medicate as appropriate Offer foods/fluids to minimize nausea/vomiting Small, frequent meals Avoid high purine and citric acid Ice chips/ice pops to decrease mouth pain

    Assess skin integrityMonitor IV siteNo rectal temps or OTC suppositories

  • 8/6/2019 Web Drugs for Neoplasia

    18/22

    General Teaching Points

    Reliable contraceptionNo breast feeding

    Hearing screening during therapyImmediately report s/s of ototoxicityImmediately report s/s of anemia, infection,

    blood dyscrasias, gout/kidney stones, rashesAvoid crowds or anyone with respiratoryinfection

  • 8/6/2019 Web Drugs for Neoplasia

    19/22

    General Teaching Points

    Good oral careInform that hair loss is possible

    Inform regarding: Women: amenorrhea, menstrual irregulrities,

    sterility Men: impotence

    Avoid citric acid and high purine foodsSmall frequent meals

  • 8/6/2019 Web Drugs for Neoplasia

    20/22

    Key Drug Specific Points

    Platinum alkylating agents: hearing lossAntimetabolites:

    temperature monitoring Monitor IV site for extravasation

    Antitumor Antibiotics: Weekly CBC with diff, platelet count May need prophylactic antibiotics Baseline assessment of cardiac status; ECG Potential for angioedema

  • 8/6/2019 Web Drugs for Neoplasia

    21/22

    Key Drug Specific Points

    Doxorubicin (Adriamycin): Gloves and protective clothing Severe vesicant

    Natural Products: Steroid therapy to ameliorate infusion hypersensitivity

    Vincristine Contraindicated in obstructive jaundice and Charcot-

    Marie-Tooth Cautiously: leukopenia, neuromuscular disease, HTN Prevent constipation Can cause severe mental depression

  • 8/6/2019 Web Drugs for Neoplasia

    22/22

    Key Drug Specific Points

    Hormones and Hormone Antagonists: All but tamoxifen may be palliative, be sure

    patient and family understand this Cross-gender secondary sex characteristics can

    develop

    Glucocorticoids: risk of STDs and infection glucose may need to adjust antidiabetic meds